Siemens and Gamma Medica ink pact

Jul 30, 2003

Siemens Medical Solutions and gamma camera developer Gamma Medica of Northridge, CA, have signed an agreement giving Siemens exclusive U.S. marketing rights for Gamma Medica’s molecular imaging product, X-SPECT. The Malvern, PA-based vendor plans to market the imaging system to hospitals, universities, and pharmaceutical and biotech companies.

The product is a second-generation dual-modality system in Gamma Medica’s MicroSPECT product line, designed for pre-clinical, small animal imaging. The X-SPECT system combines SPECT with CT, and is similar to clinical systems, but on a smaller scale and with dedicated features suited to the in vivo imaging of mice and other small animals in a laboratory setting. The systems are primarily used in the study of disease processes and for drug development.

By AuntMinnie.com staff writers
July 31, 2003
Related Reading

Siemens promotes Miller, July 29, 2003

Siemens buys MRC radiation therapy unit, July 25, 2003

Siemens medical group shows strong Q3, July 24, 2003

Siemens, MGH to partner on molecular imaging, July 22, 2003

Siemens negotiates deal with CareCore National, July 17, 2003

$ChatGPT powered by GPT-4 and using DALL-E−3 was asked to generate an image for teaching purposes that demonstrated: a nuclear medicine bone scan with skeletal metastases (top left); coronary artery disease (top right); an F-18 FDG-PET scan of the brain with Alzheimer's disease (bottom left); and an x-ray showing a fracture (bottom right). These are misleading for educational purposes and for patients who may be searching for information. Image and caption courtesy of Radiography.$